This is a prospective study with 20 patients planned to be enrolled. Patients who participate will be followed for 5 years after the surgery in which the stent graft was implanted. This will include the following schedule: A CT with and without contrast and echocardiogram 30 days after the Medtronic device is implanted, CT with and without contrast at 6 and 12 months post procedure and once a year from 2 years thru 5 years after the implant.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient must have a Type A thoracic aortic dissection, retrograde Type A thoracic aortic dissection, intramural hematoma, penetrating ulcer or pseudoaneurysm of the ascending thoracic aorta affecting the area between the Sinus of Valsalva and the innominate artery orifice (with no involvement of the aortic valve) and be considered candidates for endovascular repair;
Patient must also have at least one cm proximal and distal landing zones in the ascending aorta between 28-44 mm in diameter;
The patient must be deemed high-risk surgical candidate according to the following established criteria: ASA (American Society of Anesthesiologists) class IV.
You may not be if
Pregnant or pediatric patients (younger than 21 years of age);
Patients who have a condition that threatens to infect the stent graft/aortic valve prosthesis;
Patients with allergies to the stent graft material;
Patients or their legally authorized representatives who do not sign the informed consent;
Patients with expected survival less than one year.
Clareo Health | Feasibility of Endovascular Repair Of Ascending Aortic Pathologies
